Kimberly-Clark-Kenvue deal approved in Australia with conditions
( September 2, 2026, 06:17 GMT | Official Statement) -- MLex Summary: Kimberly-Clark's bid for consumer health company Kenvue has received regulatory approval with conditions in Australia. In a statement on Wednesday, the Australian Competition & Consumer Commission said that the clearance is subject to conditions that Kimberly-Clark divest Kenvue’s Carefree and Stayfree period care brands in Australia to a purchaser approved by the regulator. Kimberly-Clark and Kenvue are two of the three major suppliers of period care products in Australia. The regulator said that the divestiture “will preserve an independent competitor in the supply of period care products in Australia and maintain the competition that would otherwise be lost through the acquisition.”Statement follows. Summary of reasons is attached....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.